15 July 2011 in Physical Review E
We measure the anisotropy of the crystal-fluid interfacial free energy in soft colloidal systems. A temperature gradient is used to direct crystal nucleation and control the growth of large single crystals in order to achieve well-equilibrated crystal-fluid interfaces. Confocal microscopy is used to follow both the growth process and the equilibrium crystal-fluid interface at the particle scale: heterogeneous crystal nucleation, the advancing interface, and the stationary equilibrium interface. We use the measured growth velocity to determine the chemical potential difference between crystal and fluid phases. Well-equilibrated, large crystal-fluid interfaces are then used to determine the interfacial free energy and its anisotropy directly from thermally excited interface fluctuations. We find that while the measured average interfacial free energy is in good agreement with values found in simulations, the anisotropy is significantly larger than simulation values. Finally, we investigate the effect of impurities on the advancing interface. We determine the critical force needed to overcome impurity particles from the local interface curvature. DOI: http://dx.doi.org/10.1103/PhysRevE.84.011607 ©2011 American Physical Society
12 April 1999 in Applied Physics Letters
The ultrasonic attenuation in N-isopropylacrylamide (NIPA) gel has been measured as a function of temperature at various frequencies. It is found that at room temperature, the attenuation of a longitudinal ultrasonic wave in the gel is small and close to that of pure water. However, as the temperature increases above the spinodal phase transition point of the gel, the attenuation increases drastically. This change of the attenuation is completely reversible and due to the microdomains formed in the NIPA gel above its phase transition temperature. The increase of attenuation at 15 MHz from 26 to is about 26 dB/cm. The attenuation varies within 5 min after the temperature change is made for a sample with diameter 1 cm and height 0.8 cm. The results reported here may have potential applications from ultrasonic assisted drug release to a switch for ultrasonic signals.
26 February 1999 in Macromolecules
1 June 2025 in APL Materials
Diabetic wounds are characteristically difficult to heal, have a risk of serious long-term effects, and can lead to amputation and death in severe cases. In addition to routine blood glucose control, dressing is a promising diabetic wound treatment. Bionic hydrogels are novel biomaterials that combine the advantages of biomimetics and hydrogels, resulting in good biocompatibility and water retention and, thus, ideal wound dressing characteristics. A significant amount of research has gone into the pathogenesis of diabetic wounds, which has guided the design of bionic hydrogels with special functions for treating diabetic wounds and supported novel therapeutic interventions. This review provides a detailed overview of bionic hydrogel materials and their construction methods and summarizes bionic hydrogel treatments for diabetic wounds to provide a theoretical basis for future developments.
1 November 2024 in APL Materials
With the rapid increase in the number of patients with diabetes, exploring more effective and convenient methods to lower blood sugar levels is becoming increasingly important. Biomaterials are a potential solution in this field, owing to their unique customizability and biocompatibility. These materials can be used in smart drug delivery systems to achieve precise control of insulin release, or as islet cell encapsulation materials to achieve effective transplantation of islet cells. Among these, new responsive biomaterials can automatically adjust the release of insulin according to real-time changes in blood sugar levels, thereby enabling personalized and automated treatment. In addition, biomaterials are used to develop noninvasive blood glucose monitoring technologies to further simplify diabetes management. Although these applications are still in the research or early pilot stage, their potential to improve diabetes treatment and the quality of life of patients is already evident. In this Review, we discuss the current progress, limitations, and potential of biomaterials for the treatment of diabetes and its complications.